Oral Minoxidil Improves Background Hair Thickness in Lichen Planopilaris Article summary by Song Park, MD | Board-Certified Dermatologist | University of Washington Department of Dermatology Low-dose oral minoxidil (LDOM) has been increasingly used for a variety of hair loss conditions. Recent paper reports that LDOM may improve thickness of existing hairs in lichen planopliaris [...]
Cetirizine for Hair Loss? Article Summary by Soneet Dhillon, MS | MD Candidate | Chicago Medical School What is Cetirizine? Cetirizine (Zyrtec ®) is an oral antihistamine available over the counter, which is typically used to relieve allergy symptoms such as watery eyes, runny nose, sneezing, and itching. Historically, cetirizine has only been used [...]
Advocating for ICD-10-CM Coding for Central Centrifugal Cicatricial Alopecia (CCCA) and Frontal Fibrosing Alopecia (FFA). What is an ICD-10-CM code? ICD-10 codes are alphanumeric codes used by doctors, health insurance companies, and public health agencies across the world to represent diagnoses. Every disease, disorder, injury, infection, and symptom should have its own ICD-10 code, [...]
Low Dose Oral Minoxidil in female patients with Lichen planopilaris: Real-life experience Article Summary by Wonder Edem | MD Candidate 2024 |University of California, Riverside School of MedicineLichen planopilaris (LPP) is one of the most common forms of scarring hair loss. It mainly affects women within ages from 40 to 60. For patients with LPP, the [...]
Treatment of lichen planopilaris with baricitinib: A retrospective study Article summary by Wonder Edem-Ineama | MD Candidate 2024 | University of California, Riverside School of Medicine. Lichen Planopilaris and Frontal Fibrosing Alopecia are inflammatory cicatricial alopecia disorders. A retrospective study was completed on whether Baricitinib, an inhibitor of the JAK-1/2 signaling pathway, can alleviate [...]
Patch testing and contact allergen avoidance in patients with lichen planopilaris and/or frontal fibrosing alopecia: A cohort study Article summary by Jessica Brown-Korsah | MD Candidate 2024 | Case Western Reserve University School of Medicine. There has been increasing evidence that lichen planopilaris/frontal fibrosing alopecia (LPP/FFA) may be caused by different environmental exposures. However, [...]
My Advice to Fellow Scarring Alopecia Patients by Chandra Kasakevich, Patient and SAF Board Member October 12, 2022 After years of reading social media posts, and my own journey since my official diagnosis in 2015, I wanted to share some advice in terms of advocacy that I have learned over the years: Do not assume that [...]
New Potential Treatment – Narrowband UV-B for Lichen Planopilaris (LPP) Lichen planopilaris (LPP) is one of the most common scarring hair loss conditions, which is characterized by inflammation and scarring change of hair follicles under microscope. Phototherapy using particular wavelength of light (narrow band ultraviolet B therapy, NBUVB) has been successfully used for many inflammatory [...]
Management of Scarring Alopecia CARF MSAB member, Jerry Shariro, MD shares his presentation on the difference in scarring alopecia at the Maui Derm NP+PA Fall Conference. Click HERE to view the presentation information as posted in Dermatology Times.
Medical Treatment Options for Hair Loss: Differences and Similarities in Common Medications Used for Cicatricial (Scarring) Alopecia Jennifer A. Wintringham Cicatricial (scarring) hair loss has a variety of different treatment options which can be overwhelming to patients. In general, all these medications are used to reduce or halt the progression of hair loss, control [...]
